Blue Whale Capital LLP Boston Scientific Corp Transaction History

Blue Whale Capital LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $37.5 Million - $42.1 Million	-1,062,458 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $6.36 Million - $8.05 Million	191,800 Added 22.03%	1,062,458 $38.2 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $7.94 Million - $9.73 Million	230,458 Added 36.0%	870,658 $33.3 Million
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $4.86 Million - $6.3 Million	161,000 Added 33.6%	640,200 $22.5 Million
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $4.3 Million - $7.61 Million	166,500 Added 53.25%	479,200 $15.6 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $11.8 Million - $14.2 Million	312,700 New	312,700 $14.1 Million

1,478

1.21B

8.13M

8.41M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $124B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Blue Whale Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Blue Whale Capital LLP with notifications on news.